1. Home
  2. VSECU vs OGN Comparison

VSECU vs OGN Comparison

Compare VSECU & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VSE Corporation Tangible Equity Units

VSECU

VSE Corporation Tangible Equity Units

N/A

Current Price

$53.93

Market Cap

1.6B

Sector

N/A

ML Signal

N/A

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.43

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VSECU
OGN
Founded
N/A
1923
Country
United States
United States
Employees
1600
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
VSECU
OGN
Price
$53.93
$13.43
Analyst Decision
Hold
Analyst Count
0
5
Target Price
N/A
$11.40
AVG Volume (30 Days)
27.6K
2.4M
Earning Date
N/A
05-07-2026
Dividend Yield
N/A
0.60%
EPS Growth
N/A
N/A
EPS
N/A
0.55
Revenue
N/A
$6,216,000,000.00
Revenue This Year
N/A
$0.45
Revenue Next Year
N/A
$1.67
P/E Ratio
N/A
$24.42
Revenue Growth
N/A
N/A
52 Week Low
$38.45
$5.69
52 Week High
$65.93
$13.49

Technical Indicators

Market Signals
Indicator
VSECU
OGN
Relative Strength Index (RSI) 69.20 72.03
Support Level $44.69 $10.05
Resistance Level $58.94 $13.46
Average True Range (ATR) 3.47 0.05
MACD 1.08 -0.11
Stochastic Oscillator 81.20 57.14

Price Performance

Historical Comparison
VSECU
OGN

About VSECU VSE Corporation Tangible Equity Units

VSE Corp is a diversified aftermarket products and services company serving commercial and government markets. The Company's operations include aircraft and airframe parts supply and distribution, and MRO services of aircraft components and engine accessories. The Company operates as a single reportable segment: Aviation, which is a provider of aftermarket parts distribution and MRO services for components and engine accessories supporting commercial, business, and general aviation operators.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: